Last reviewed · How we verify

NCT06575231

Accuracy and User Performance Evaluation of PixoTest HbA1c Measurement System

Completed NA Last updated 28 August 2024
What this trial tests

NA trial testing in-vitro in Diabetes in 80 participants. Completed in 30 June 2017.

Timeline
1 July 2016
Primary endpoint
17 May 2017
30 June 2017

Quick facts

Lead sponsorChina Medical University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment80
Start date1 July 2016
Primary completion17 May 2017
Estimated completion30 June 2017

Drugs / interventions tested

Conditions studied

Sponsor

China Medical University Hospital

Who can join

20 and older, any sex, with Diabetes or HbA1c. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the accuracy user performance of PixoTest HbAc1 measurement system and to collect feedback from subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetes

Currently open trials in the same condition.

Other China Medical University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06575231.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing